135 related articles for article (PubMed ID: 26598500)
1. The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma.
Shi RL; Liao T; Qu N; Liang F; Chen JY; Ji QH
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):256-62. PubMed ID: 26598500
[TBL] [Abstract][Full Text] [Related]
2. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
Su A; Zhao W; Wu W; Wei T; Ruan M; Li Z; Zhu J
Am J Surg; 2020 Sep; 220(3):634-641. PubMed ID: 31955813
[TBL] [Abstract][Full Text] [Related]
3. Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?
Yazici P; Mihmanli M; Bozkurt E; Ozturk FY; Uludag M
Hormones (Athens); 2016 Apr; 15(2):256-263. PubMed ID: 27376428
[TBL] [Abstract][Full Text] [Related]
4. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
Jin J; Machekano R; McHenry CR
Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
[TBL] [Abstract][Full Text] [Related]
6. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
Gao Y; Qu N; Zhang L; Chen JY; Ji QH
Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
[TBL] [Abstract][Full Text] [Related]
7. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in differentiated thyroid carcinoma and microcarcinoma.
Lupoli R; Cacciapuoti M; Tortora A; Barba L; Verde N; Romano F; Vastarella M; Fonderico F; Masone S; Milone M; Lupoli G; Lupoli GA
Int J Surg; 2014; 12 Suppl 1():S148-51. PubMed ID: 24859408
[TBL] [Abstract][Full Text] [Related]
9. An overall and dose-response meta-analysis for thyrotropin and thyroid cancer risk by histological type.
Hu N; Li ZM; Liu JF; Zhang ZZ; Wang LS
Oncotarget; 2016 Jul; 7(30):47750-47759. PubMed ID: 27351286
[TBL] [Abstract][Full Text] [Related]
10. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma.
Sugitani I; Fujimoto Y; Yamada K
World J Surg; 2014 Mar; 38(3):673-8. PubMed ID: 24233662
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis.
McLeod DS; Watters KF; Carpenter AD; Ladenson PW; Cooper DS; Ding EL
J Clin Endocrinol Metab; 2012 Aug; 97(8):2682-92. PubMed ID: 22622023
[TBL] [Abstract][Full Text] [Related]
12. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin serum concentrations in patients with papillary thyroid microcancers.
Gerschpacher M; Göbl C; Anderwald C; Gessl A; Krebs M
Thyroid; 2010 Apr; 20(4):389-92. PubMed ID: 20210672
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer.
Zheng J; Li C; Lu W; Wang C; Ai Z
Oncotarget; 2016 Jun; 7(23):34918-29. PubMed ID: 27166998
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
[TBL] [Abstract][Full Text] [Related]
16. Preoperative TSH and thyroglobulin levels: would it predict thyroid cancer?
Al-Bader A; Zawawi F; Singer Z; Mlynarek A; Hier M; Tamilia M; Payne R
Otolaryngol Pol; 2015; 69(3):21-5. PubMed ID: 26388246
[TBL] [Abstract][Full Text] [Related]
17. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
Zhao T; Liang J; Guo Z; Li J; Lin Y
Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
[TBL] [Abstract][Full Text] [Related]
18. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
Moon SS; Lee YS; Lee IK; Kim JG
Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
[TBL] [Abstract][Full Text] [Related]
19. An elevated level of TSH might be predictive of differentiated thyroid cancer.
Dorange A; Triau S; Mucci-Hennekinne S; Bizon A; Laboureau-Soares S; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2011 Dec; 72(6):513-21. PubMed ID: 22115282
[TBL] [Abstract][Full Text] [Related]
20. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]